InvestorsHub Logo

BigJuan

06/04/18 2:50 PM

#81728 RE: BigJuan #81727

“As part of our strategic plan to acquire interests in growing companies, we felt a partnership and distribution agreement with Unosoftware was in the best interests of SPO’s shareholders. SPO will receive a share of the revenues generated on the product line and will realize a reduction of over $ 350,000 of debt and accounts payable from its balance sheet”, stated Stuart Barton, President of SPO Global.”

TEFFY

06/04/18 6:39 PM

#81729 RE: BigJuan #81727

Nice read there brother , looking like SPOM is about ready for a possible move. Pretty solid news , surprised the trading wasn't bigger today ,news like that could light up a ticker.

Guessing much more to come , SPOM is in the building stages and creating a good business model.

Lotta work being done and fer a reason is my guess :-)

BottomBounce

06/05/18 12:04 PM

#81735 RE: BigJuan #81727

$INSY "SYNDROS® is a cannabinoid medicine used in adults to treat:

Loss of appetite (anorexia) in people with AIDS (Acquired Immune Deficiency Syndrome) who have lost weight
Nausea and vomiting caused by anti-cancer medicine (chemotherapy) in people whose nausea and vomiting have not improved with usual anti-nausea and vomiting medicines
SYNDROS® is the first and only FDA-approved liquid dronabinol, which allows for fast absorption, flexible dosing and a potential solution for patients who may prefer a liquid medication."

https://www.insysrx.com/products/approved